The association between p16Ink4A overexpression and patients’ survival in lung cancer has been widely investigated, and there are several lines of evidence to suggest that p16Ink4A could play a part in lung cancer tumorigenesis [3, 17–19]. Here, CDKN2A is linked to lung cancer.